Four lanes, two prices, one billing term
Injectable and oral semaglutide carry the same figure; injectable and oral tirzepatide carry the same higher one. Each is presented as a per-month rate and then, in the next line, as a total for a first three months on a three-month billing plan.
So the number is a prepayment expressed monthly. We have recorded all four as not monthly, with the plan term in the qualifier, because the amount actually charged is the three-month total.
The page directs a returning buyer to a "Current User" column for standard and renewal rates. That column does not carry a figure on the page we read.
The table next to the prices is about other companies
Below its own plans, the site prints a comparison table of unnamed rivals with prices, membership-fee ticks and dose-pricing ticks. Those are not its prices, and it says so in a disclaimer beneath.
None of them is recorded here. This is the specific trap that produces false price rows: a rival’s number sitting in the same visual block as the seller’s own.
The table does carry one fact about NuuVim itself worth keeping — its own row is ticked in the no-membership-fees column — and that is the basis for the membership status recorded here.
NuuVim's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $79⛔ A THREE-MONTH PREPAYMENT: "$79 / month · $237 Total First 3 months · 3-month billing plan · See “Current User” for standard and renewal rates" — and the renewal rate is not printed on the page | September 2026source |
| Semaglutide (compounded-oral) | $79"COMPOUNDED Starting at $79/mo | New GLP-1 Users · Semaglutide Oral · Daily oral liquid", priced on the same three-month billing plan as the injection | September 2026source |
| Tirzepatide (compounded) | $133"COMPOUNDED Starting at $133/mo | New GLP-1 Users · Tirzepatide Injectable", on the same three-month billing plan | September 2026source |
| Tirzepatide (compounded-oral) | $133"COMPOUNDED Starting at $133/mo | New GLP-1 Users · Tirzepatide Oral · Daily oral liquid" | September 2026source |
| Semaglutide (brand) | $1,498/mo"Starting at $1,498/mo Ozempic TM One simple injection per week" | September 2026source |
| Tirzepatide (brand) | $1,892/mo"Starting at $1,892/mo Zepbound TM One simple injection per week" | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 240 providers reviewed here are paid partners today; the other 236 are not. See how this works.
See NuuVim's current price →Good fit if
- Readers comparing an oral and an injectable price for both molecules.
- Buyers willing to take a three-month billing plan.
- People who want two brand-name lanes priced beside compounded ones.
Look elsewhere if
- Anyone who needs the renewal rate before committing.
- Buyers who want month-to-month billing.
- Readers who want a named pharmacy, clinician or service area.
- People who find a competitor table beside a price list confusing.
How this review was verified
- Re-read the homepage, the pricing page, the FAQ and both legal pages on 7 September 2026, comparing requested to effective URLs with a nonsense path against the host in the same run, which returned a 404.
- Recorded all four compounded figures as not monthly, because the page states a three-month billing plan and prints the three-month total beside each.
- Excluded every figure in the competitor comparison table, which the seller itself attributes to other companies.
- Read the business-formation vendor named in its copyright-agent block in context and rejected it as the operator.
- Screened the brand against FDA’s live warning-letter datatable with both controls green in the same invocation: no letter found.